Landscapes / Targets

thrombopoietin receptor

5 drugs act on thrombopoietin receptor, in 8 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs5

DrugHow it worksCompanyStageNext dateDetails
—
Approved 30 Jun 2028Phase 2/3 trial completes
—
Hengrui · Public 600276.SS
Approved in China Dec 2028Phase 3 trial completes
Thrombopoietin receptor agonist
Amgen · Public AMGN
Approved 14 Sep 2029Phase 3 trial completes
—
Phase 3 30 Apr 2027Phase 2/3 trial completes
GP40141not checked
—
Phase 3 31 Mar 2028Phase 3 trial completes

About this list

Checked
4 of 5 drugs. The other 1 is marked “not checked” in the list. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Thrombopoietin receptor

Following is part of Solo: you see every change to Thrombopoietin receptor the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in